Skip to content

Soluble Fibrin Monomer Complex (Serum)

Published: August 9, 2026Updated: August 16, 2026

This test measures the presence of soluble fibrin monomer, a protein fragment that forms during blood clotting. It helps assess whether your blood has clotted abnormally or if there’s a risk of bleeding.

Quick summary

["This test helps evaluate blood clotting disorders or bleeding risks."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
32219-8
Short code
Soluble liver Ab Ser IA-aCnc
Synonyms
Soluble liver Ab Ser IA-aCnc
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
ia
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may recommend this test if you have symptoms like excessive bleeding, unexplained bruising, or signs of clotting issues (e.g., blood clots in veins or arteries). It’s also used in cases of suspected disseminated intravascular coagulation (DIC), a rare but serious condition where clotting and bleeding occur simultaneously.

What to Expect Before the Test

No special preparation is needed. You may have a small needle inserted into a vein (usually in your arm) to draw blood. If you’re on blood-thinning medications, let your provider know before the test.

What the Results Mean

Higher than expected levels may suggest recent clotting activity or conditions like DIC. Lower levels might indicate bleeding disorders or medications that interfere with clotting. Results are interpreted by your provider based on your medical history and symptoms.

Common Conditions Linked to This Test

This test is often used to diagnose or monitor conditions such as thrombotic disorders (e.g., deep vein thrombosis), bleeding disorders (e.g., hemophilia), or complications from trauma, surgery, or infections.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Soluble fibrin monomer is a marker for fibrin degradation products, which appear when clots break down. Elevated levels can indicate active clotting (e.g., in venous thromboembolism) or clotting-related complications. It’s particularly useful in cases where other clotting factors may be unstable or mixed with bleeding risks, such as in DIC.

Short name

Soluble Fibrin Monomer

Frequently asked questions

How long does it take to get results from this test?
Results are typically available within 1 to 2 business days, depending on your lab’s processing schedule. Your provider will discuss the findings with you during your follow-up visit.
Can I eat or drink before this test?
You can eat and drink normally before this test unless instructed otherwise by your provider. No fasting is required.
What should I do if I have a bleeding disorder or take blood thinners?
If you have a bleeding disorder or are on blood-thinning medications (e.g., warfarin, heparin), inform your healthcare provider before the test. They may adjust your treatment or monitor you more closely to avoid complications.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy